vs
斗鱼（DOYU）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是斗鱼的1.3倍（$197.9M vs $147.1M）
斗鱼国际控股有限公司运营中国头部游戏直播平台，核心业务涵盖电竞赛事直播、休闲游戏实况、泛娱乐互动内容放送等，核心用户以年轻游戏爱好者为主，主要收入来源于观众虚拟打赏、品牌广告合作及付费会员服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
DOYU vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.3倍
$147.1M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $147.1M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | 13.5% | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOYURGEN
| Q4 25 | — | $197.9M | ||
| Q3 25 | — | $188.8M | ||
| Q2 25 | $147.1M | $182.4M | ||
| Q1 25 | $130.5M | $169.2M | ||
| Q4 24 | — | $174.1M | ||
| Q3 24 | — | $154.9M | ||
| Q2 24 | $142.0M | $154.1M | ||
| Q1 24 | $144.0M | $151.3M |
净利润DOYURGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | — | $14.9M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | $-11.0M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | — | $-654.0K | ||
| Q2 24 | $-6.8M | $3.3M | ||
| Q1 24 | $-12.2M | $2.1M |
毛利率DOYURGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | 13.5% | 50.0% | ||
| Q1 25 | 12.0% | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | 8.2% | 49.8% | ||
| Q1 24 | 10.5% | 49.5% |
营业利润率DOYURGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | — | 8.9% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | -2.8% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | -11.6% | 1.0% | ||
| Q1 24 | -16.1% | 1.3% |
净利率DOYURGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | — | 8.2% | ||
| Q1 25 | -8.4% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | -4.8% | 2.2% | ||
| Q1 24 | -8.5% | 1.4% |
每股收益（稀释后）DOYURGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $214.4M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $279.9M | $2.1B |
| 总资产 | $448.1M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资DOYURGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | $214.4M | $708.9M | ||
| Q1 25 | $35.2M | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | $558.8M | $809.1M | ||
| Q1 24 | $70.7M | $780.6M |
总债务DOYURGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DOYURGEN
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | $279.9M | $2.1B | ||
| Q1 25 | $37.4M | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $895.6M | $2.0B | ||
| Q1 24 | $126.4M | $2.0B |
总资产DOYURGEN
| Q4 25 | — | $2.9B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | $448.1M | $2.9B | ||
| Q1 25 | $60.8M | $2.9B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | $1.1B | $2.9B | ||
| Q1 24 | $156.2M | $2.8B |
负债/权益比DOYURGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流DOYURGEN
| Q4 25 | — | $25.7M | ||
| Q3 25 | — | $48.1M | ||
| Q2 25 | — | $28.6M | ||
| Q1 25 | — | $15.0M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | — | $49.3M | ||
| Q2 24 | — | $42.2M | ||
| Q1 24 | — | $44.7M |
自由现金流DOYURGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率DOYURGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度DOYURGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率DOYURGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
